Sign in

CIK 0000914475 · Large accelerated filer

NEUROCRINE BIOSCIENCES INC

Sign in to watch
Ticker
NBIX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
330525145
Phone
(858) 617-7600
Business address
6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,162,347
in 4 filings, $3.2M under 10b5-1 plans

Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-01-31 BENEVICH ERIC Chief Commercial Officer Shares withheld for taxes −1,292 $136.06 $176K 52,755
2026-01-31 BENEVICH ERIC Chief Commercial Officer Option exercise · Restricted Stock Unit −2,294 0
2026-01-31 Gano Kyle Chief Executive Officer Option exercise +2,927 143,334
2026-01-31 Gano Kyle Chief Executive Officer Shares withheld for taxes −1,580 $136.06 $215K 141,754
2026-01-31 Gano Kyle Chief Executive Officer Option exercise · Restricted Stock Unit −2,927 0
2026-01-31 Lippoldt Darin Chief Legal Officer Option exercise +2,373 49,127
2026-01-31 Lippoldt Darin Chief Legal Officer Shares withheld for taxes −1,335 $136.06 $182K 47,792
2026-01-31 Lippoldt Darin Chief Legal Officer Option exercise · Restricted Stock Unit −2,373 0
2026-01-31 GORMAN KEVIN CHARLES Director Option exercise +5,142 519,738
2026-01-31 GORMAN KEVIN CHARLES Director Shares withheld for taxes −2,845 $136.06 $387K 516,893
2026-01-31 GORMAN KEVIN CHARLES Director Option exercise · Restricted Stock Unit −5,142 0
2026-01-16 Gano Kyle Chief Executive Officer Option exercise 10b5-1 +34,588 $35.99 $1.2M 174,995
2026-01-16 Gano Kyle Chief Executive Officer Sale 10b5-1 −34,588 $132.70 $4.6M 140,407
2026-01-16 Gano Kyle Chief Executive Officer Option exercise 10b5-1 +1,812 $35.99 $65K 142,219
2026-01-16 Gano Kyle Chief Executive Officer Sale 10b5-1 −1,812 $132.71 $240K 140,407
2026-01-16 Gano Kyle Chief Executive Officer Option exercise · Non-Qualified Stock Option 10b5-1 −34,588 0
2026-01-16 Gano Kyle Chief Executive Officer Option exercise · Incentive Stock Option 10b5-1 −1,812 0
2026-01-08 Lippoldt Darin Chief Legal Officer Option exercise +3,349 $35.99 $121K 46,754
2026-01-08 Lippoldt Darin Chief Legal Officer Option exercise · Incentive Stock Option −3,349 0
2025-12-16 Norwalk Leslie V Director Sale 10b5-1 −1,190 $155.09 $185K 6,239

Page 15 of 49 · 963 trades